LCTX icon

Lineage Cell Therapeutics (LCTX)

AMEX

(

NaN%

)

1D
5D
1M
6M
1Y
5Y
Market closed

LCTX: / ₿ NaN BTC / NaN Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$0.37 - $2.09
$439.93M
0.1
230.33M
-
No

What is Lineage Cell Therapeutics (LCTX)?

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

The Lineage Cell Therapeutics (LCTX) stock price has been falling

The Lineage Cell Therapeutics, Inc. (LCTX) stock price today is , reflecting a NaN% move since the market opened. The company’s market capitalization stands at $439.93M, with a daily trading volume of shares. The previous closing price was .

Get started with Lineage Cell Therapeutics (LCTX)

Ready to get started? Follow the steps below, or read our guide on how to buy Lineage Cell Therapeutics stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy LCTX

Search for LCTX in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy LCTX.

LCTX FAQs

LCTX is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

LCTX is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Lineage Cell Therapeutics, Inc. (LCTX) has traded between a low of $0.37 and a high of $2.09.

LCTX is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Lineage Cell Therapeutics? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
LCTX icon
LCTX

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy Lineage Cell Therapeutics in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

Top losers

Compare the worst-performing stocks of 
the day

OTRKQ icon

OTRKQ

YOTAR icon

YOTAR

CRESW icon

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.